Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 328

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Linezolid: The First Oxazolidinone Antimicrobial

Paterson, David L., Pasculle, A. William, McCurry, Kenneth · 2003 · Annals of Internal Medicine

Abstract

Letters18 November 2003Linezolid: The First Oxazolidinone AntimicrobialDavid L. Paterson, MBBS, FRACP, A. William Pasculle, ScD, and Kenneth McCurry, MDDavid L. Paterson, MBBS, FRACPFrom University of Pittsburgh Medical Center; Pittsburgh, PA 15213.Search for more papers by this author, A. William Pasculle, ScDFrom University of Pittsburgh Medical Center; Pittsburgh, PA 15213.Search for more papers by this author, and Kenneth McCurry, MDFrom University of Pittsburgh Medical Center; Pittsburgh, PA 15213.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-139-10-200311180-00017 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:In his excellent review of the new antibiotic linezolid (1), Dr. Moellering notes the recent emergence of resistance of S. aureus to linezolid. At the time the review was written, resistance had been detected in only 1 patient (2, 3). We describe an additional case of linezolid-resistant S. aureus infection in which failure of anti-staphylococcal therapy led to death of the patient.A 49-year-old man underwent single lung transplantation for silicosis. Eleven months after transplantation, the patient developed increasing dyspnea that necessitated hospitalization and mechanical ventilation. Two days later, radiography of the chest showed bilateral consolidation. Cultures ...References1. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003;138:135-42. [PMID: 12529096] LinkGoogle Scholar2. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, . Linezolid resistance in a clinical isolate of Staphylococcus aureus [Letter]. Lancet. 2001;358:207-8. [PMID: 11476839] CrossrefMedlineGoogle Scholar3. Pillai SK, Sakoulas G, Wennersten C, Eliopoulos GM, Moellering RC, Ferraro MJ, . Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis. 2002;186:1603-7. [PMID: 12447736] CrossrefMedlineGoogle Scholar4. Wilson P, Andrews JA, Charlesworth R, Walesby R, Singer M, Farrell DJ, . Linezolid resistance in clinical isolates of Staphylococcus aureus [Letter]. J Antimicrob Chemother. 2003;51:186-8. [PMID: 12493812] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: David L. Paterson, MBBS, FRACP; A. William Pasculle, ScD; Kenneth McCurry, MDAffiliations: From University of Pittsburgh Medical Center; Pittsburgh, PA 15213. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoLinezolid: The First Oxazolidinone Antimicrobial Robert C. Moellering Jr. Linezolid: The First Oxazolidinone Antimicrobial Robert C. Moellering Jr. Linezolid: The First Oxazolidinone Antimicrobial James R. Johnson Linezolid: The First Oxazolidinone Antimicrobial D. A. Lindley Metrics Cited byDesigning strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapyLinezolid Resistance in Enterococcus faecalis Associated With Urinary Tract Infections of Patients in a Tertiary Hospitals in China: Resistance Mechanisms, Virulence, and Risk FactorsNew antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug developmentMacrolide, Lincosamide, Streptogramin, Ketolide, and Oxazolidinone ResistanceMicrobiology of drugs for treating multiply drug-resistant Gram-positive bacteriaEmerging Options for Treatment of Invasive, Multidrug-Resistant Staphylococcus aureus InfectionsAn infection with linezolid-resistant S. aureus in a patient with left ventricular assist systemEpidemiological Profile of Linezolid‐Resistant Coagulase‐Negative StaphylococciRole of linezolid in the treatment of complicated skin and soft tissue infectionsClinical Characteristics of Linezolid-Resistant Staphylococcus aureus InfectionsMechanisms of Resistance of Bacteria Causing Ventilator-Associated PneumoniaAntimicrobial Resistance to Linezolid 18 November 2003Volume 139, Issue 10Page: 863-864KeywordsAntibiotic resistanceAntibioticsBloodMethicillin-resistant staphylococcus aureusPneumoniaThoraxTransplantationUpper respiratory tract infectionsVancomycinVentilators ePublished: 18 November 2003 Issue Published: 18 November 2003 Copyright & PermissionsCopyright © 2003 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-139-10-200311180-00017

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 328

Metadata

Authors
Paterson, D. L., Pasculle, A. W., & McCurry, K.
Venue
Annals of Internal Medicine
Published
2003-11-18
Volume
139
Issue
10
Pages
863-864
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2039196311
Cited by
328
References
36
FWCI
16.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Linezolid: The First Oxazolidinone Antimicrobial. https://app.cochat.ai/papers/10.7326/0003-4819-139-10-200311180-00017
The paper
Paterson, D. L., Pasculle, A. W., & McCurry, K. (2003). Linezolid: The First Oxazolidinone Antimicrobial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-139-10-200311180-00017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.